Evolent Health Inc (EVH)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $554.22M
Last updated: Nov 17, 2026 at 4:15 PM ET
Evolent Health Inc (EVH) Statistics
Evolent Health (EVH) has a market cap of $554.22M and an enterprise value of $1.38B. Its net debt of $821.23M equals 148.18% of its market cap. It kept -21.67% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 148.18% above the market cap, as debt exceeds cash.
| Market Cap | $554.22M |
|---|---|
| Enterprise Value | $1.38B |
| Latest price (Nov 17, 2026) | $4.62 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 1.4x. Its year-end P/S ranged from 0.2x to 2.7x from 2016 to 2025.
| Forward P/E | 22.1x |
|---|---|
| P/S Ratio | 0.2x |
| Forward P/S | 0.2x |
| P/B Ratio | 1.4x |
| P/FCF Ratio | 14.2x |
| P/OCF Ratio | 8.5x |
Enterprise Valuation
Counting debt and cash, the company is valued at 36.6x free cash flow.
| EV / Sales | 0.6x |
|---|---|
| EV / FCF | 36.6x |
Price Statistics
The stock is up 10.41% over 52 weeks and trades 8.96% above its 50-day average.
| Beta (1Y) | 1.02 |
|---|---|
| 52-Week Change | +10.41% |
| 1-Month Change | +3.01% |
| 3-Month Change | +0.76% |
| 6-Month Change | +18.64% |
| 5-Year Change | -85.31% |
| 10-Year Change | -79.57% |
| Total Return (1Y) | +10.41% |
| Total Return (3Y CAGR) | -46.01% |
| Total Return (5Y CAGR) | -30.91% |
| Return vs SPY (1Y) | +3.82% |
| Max Drawdown (1Y) | -50.24% |
| Max Drawdown (3Y) | -93.75% |
| Sharpe Ratio (1Y) | 0.19 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $4.24 |
| 200-Day Average | $3.93 |
| 52-Week Range | $2.10 to $6.25 |
| RSI (14 Days) | 51.4 |
| Average Volume (20 Days) | 1.70M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.26x current liabilities, and total debt is 2.60x shareholder equity.
| Current Ratio | 1.26x |
|---|---|
| Quick Ratio | 1.26x |
| Debt / Equity | 2.60x |
| Debt / FCF | 26.45x |
| Interest Coverage | -5.90x |
Returns and Efficiency
Return on invested capital is -32.37% over the last 12 months, against a 5-year average of -13.67%.
| Return on Equity (ROE) | -136.17% |
|---|---|
| Return on Assets (ROA) | -25.87% |
| Return on Invested Capital (ROIC) | -32.37% |
| Return on Capital Employed (ROCE) | -29.52% |
| ROE (5Y Average) | -30.63% |
| ROA (5Y Average) | -7.70% |
| ROIC (5Y Average) | -13.67% |
| Asset Turnover | 1.06x |
| Receivables Turnover | 5.25x |
Scores
EVH has an Altman Z-Score of -0.26, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -0.26 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.34B over the last 12 months is up 14.06% from the 12 months before.
| Revenue | $2.34B |
|---|---|
| Revenue Growth (YoY) | +14.06% |
| Gross Profit | $350.28M |
| Operating Income | -$434.58M |
| Pretax Income | -$504.63M |
| Net Income | -$507.69M |
| EBITDA | -$308.82M |
| EBIT | -$434.58M |
| Reported EPS (TTM) | -$0.09 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 19.02% of the $1.96B in total assets.
| Cash and Equivalents | $148.25M |
|---|---|
| Total Debt | $969.48M |
| Net Debt | $821.23M |
| Net Debt Per Share | $7.26 |
| Working Capital | $127.18M |
| Shareholder Equity | $372.85M |
| Book Value Per Share | $3.30 |
| Tangible Book Value | -$860.74M |
| Total Assets | $1.96B |
| Total Liabilities | $1.59B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $28.23M of capital spending, operating cash flow left $36.66M of free cash flow.
| Operating Cash Flow | $64.88M |
|---|---|
| Capital Expenditures | $28.23M |
| Free Cash Flow | $36.66M |
| FCF Per Share | $0.32 |
| Depreciation and Amortization | $125.76M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -18.55%, against a 5-year average of -6.29%.
| Gross Margin | 14.95% |
|---|---|
| Operating Margin | -18.55% |
| Pretax Margin | -21.54% |
| Net Margin | -21.67% |
| EBITDA Margin | -13.18% |
| EBIT Margin | -18.55% |
| FCF Margin | 1.56% |
| Gross Margin (5Y Average) | 22.03% |
| Operating Margin (5Y Average) | -6.29% |
| Net Margin (5Y Average) | -8.44% |
Growth
Revenue grew 11.54% a year over 3 years, and EPS fell 71.99% a year.
| Revenue Growth (3Y CAGR) | +11.54% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.20% |
| EPS Growth (3Y CAGR) | -71.99% |
| Book Value Per Share Growth (2Y CAGR) | -37.81% |
Dividends and Yields
EVH does not pay a dividend. Its free cash flow yield is 7.02%.
| FCF Yield | 7.02% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 11 similar companies, EVH has the lowest P/S.
P/S RatioPeer median 2.5x
ROICPeer median 2.72%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.73%
| P/S Ratio | 0.2x vs 2.5x median |
|---|---|
| ROIC | -32.37% vs 2.72% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +14.06% vs +7.73% median |
Analyst Forecast
Consensus estimates put revenue growth at 32.99% and EPS growth at 359.84% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +32.99% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +359.84% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About EVH
What is EVH's market cap?
Evolent Health has a market cap of $554.22M. Its enterprise value, which adds debt and subtracts cash, is $1.38B.
How many shares of EVH are outstanding?
Evolent Health has 113.07M shares outstanding. The count is down 0.87% from a year earlier.
Does EVH pay a dividend?
No. Evolent Health does not pay a dividend.
How much debt does EVH have?
Evolent Health has $969.48M of total debt and $148.25M of cash and equivalents, a net debt position of $821.23M.
EVH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors